Silo Pharma, Inc. (SILO) › Operating IncomeSilo Pharma, Inc. (SILO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$490.9K2018: -$594.2K2019: -$930.4K2020: -$2.20M2021: -$2.74M2022: -$3.63M2023: -$3.86M2024: -$4.71M2025: -$4.28M-$4.28M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$4.28M+9.0%2024-$4.71M-22.0%2023-$3.86M-6.3%2022-$3.63M-32.2%2021-$2.74M-24.6%2020-$2.20M-136.6%2019-$930.4K-56.6%2018-$594.2K-21.1%2017-$490.9K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share